Skip to main content

Table 1 Demographics and clinical characteristics of the study cohort

From: Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia

Patient characteristics

PJP

(n = 20)

PJC

(n = 22)

Control

(n = 19)

p-value

Age (years, mean ± SD)

52.90 ± 17.33

55.32 ± 14.81

51.95 ± 11.11

0.749

BMI (kg/m2, mean ± SD)

21.09 ± 3.74

20.69 ± 3.09

20.64 ± 3.23

0.644

Sex, n(%)

   

0.865

 Male

15(75.00)

15(68.18)

13(68.42)

 

 Female

5(25.00)

7(31.82)

6(31.58)

 

Primary disease, n(%)

   

0.827

 COPD

4(20.00)

7(31.82)

3(15.79)

 

 ILD

9(45.00)

10(45.45)

10(52.63)

 

 Pneumoconiosis

3(15.00)

1(4.55)

3(15.79)

 

 Others*

4(20.00)

4(18.18)

3(15.79)

 

Type of lung transplantation, n(%)

   

0.433

 Single

13(65.00)

10(45.45)

11(57.89)

 

 Bilateral

7(35.00)

12(54.55)

8(42.11)

 

Postoperative duration, Median (P25, P75), days

463(316, 851)

570(253, 731)

566(317, 712)

0.998

  1. BMI, body mass index; COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; SD, standard deviation
  2. *Other primary disease including bronchiectasis, paraquat lung, pulmonary arterial hypertension, pulmonary alveolar proteinosis, Langerhans cell histiocytosis, lymphangioleiomyomatosis, and bronchiolitis obliterans syndrome